Search results
Erin S. Calipari (born February 18, 1987) is an Associate Professor of Pharmacology at the Vanderbilt University School of Medicine Basic Sciences. Calipari looks to understand the brain circuitry that is used for adaptive and maladaptive processes in reward, associative learning and motivation.
Erin S. Calipari, Ph.D. Director. Vanderbilt Center for Addiction Research. Associate Professor. Department of Pharmacology. Department of Molecular Physiology and Biophysics. Department of Psychiatry and Behavioral Sciences. Vanderbilt Brain Institute. Vanderbilt University. Office: 865F Light Hall. Phone: 615-343-5792.
Erin S. Calipari, Ph.D. Associate Professor, Department of Pharmacology. Director of Vanderbilt Center for Addiction Research. Associate Professor of Molecular Physiology and Biophysics. Vanderbilt Brain Institute. Vanderbilt Institute for Infection, Immunology and Inflammation. : erin.calipari@vanderbilt.edu.
Erin Calipari, Vanderbilt University Assistant Professor of Pharmacology provides an overview of her research which seeks to characterize and modulate the precise circuits in the brain that underlie both adaptive and maladaptive processes in reward, motivation, and associative learning, to develop improved treatments for complex and devastating ...
ERIN S. CALIPARI, PH.D. DIRECTOR, Vanderbilt Center for Addiction Research. ASSOCIATE PROFESSOR, Pharmacology. Dr. Calipari received her PhD in Neuroscience in 2013 in the laboratory of Dr. Sara Jones at Wake Forest University School of Medicine where she studied how self-administered drugs altered dopaminergic function to drive addictive ...
Associate Professor of Psychiatry and Behavioral Sciences. 865F Light Hall. 2215 Garland Avenue. Nashville. Tennessee. 37232. erin.calipari@vanderbilt.edu. More Information. https://wag.app.vanderbilt.edu/PublicPage/Faculty/Details/44027. Dopamine, Cocaine, Drug Addiction, Motivation, Calcium Imaging, Optogentics. Research Information.
Erin S Calipari. Biological sex has been pinpointed as significant biological factor impacting the prevalence and prognosis of Substance Use Disorder (SUD). Despite the overwhelming utilization...
